AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ARTRYA LTD

3.100

+0.0802.65%

Volume:179.76K

Turnover:556.71K

Market Cap:490.06M

PE:-18.00

High:3.160

Open:3.140

Low:3.050

Close:3.020

52wk High:5.240

52wk Low:0.560

Shares:158.08M

Float Shares:76.77M

Volume Ratio:0.40

T/O Rate:0.23%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.172

EPS(LYR):-0.178

ROE:-37.89%

ROA:-23.75%

PB:5.48

PE(LYR):-17.44

Loading ...

Overview Company News Filings

Artrya Ltd - Loss for Half-Year Attributable a$10.7 Mln

THOMSON REUTERS

Artrya Ltd-Appointment of Non-Executive Director

THOMSON REUTERS

Change in substantial holding from WAX/WAA/WAM/WMI

Artrya Says US Health System Agrees to In-Principle Participation in Cardiovascular Study

MT Newswires Live

BRIEF-Artrya Appoints Richard Jarvis As CFO

Artrya Ltd - Begins Executive Search for Permanent CFO

THOMSON REUTERS

Artrya Ltd - Richard Jarvis Appointed as CFO

THOMSON REUTERS

ASX Growth Stocks With High Insider Ownership To Watch

Simply Wall St.

Artrya And 2 Other High Growth Tech Stocks With Potential In Australia

Simply Wall St.

Artrya (ASX:AYA) Secures Cone Health In Five-Year SaaS Deal Is Its U.S. Beachhead Emerging?

Simply Wall St.

Artrya Enters Agreement With US Foundation Partner for Clinical Use of Platform

MT Newswires Live

Artrya Reports First Fee per Scan Revenue From Salix Cloud Platform; Shares Hit All-Time High

MT Newswires Live

BUZZ-Australia's Artrya at three-week peak on deal with US co

Artrya Enters Agreement With US Foundation Partner for Clinical Use of Platform; Shares Rise 9%

MT Newswires Live

ASX Growth Companies With High Insider Ownership December 2025

Simply Wall St.

Exploring 3 High Growth Tech Stocks in Australia

Simply Wall St.

Artrya Says US Health System to Participate in Study on Early Coronary Artery Disease Detection; Shares Up 3%

MT Newswires Live

Assessing Artrya (ASX:AYA) Valuation Ahead of Q1 2026 Earnings Call

Simply Wall St.

Can Anticipation Around Artrya (ASX:AYA)'s Earnings Call Reveal Shifts in Investor Confidence?

Simply Wall St.

Buy Hold Sell: The hottest ASX small caps right now (and 2 on the rise)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AYA.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AYA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AYA.AU\",,,,,undefined,":{"symbol":"AYA.AU","market":"AU","secType":"STK","nameCN":"ARTRYA LTD","latestPrice":3.1,"timestamp":1772687520000,"preClose":3.02,"halted":0,"volume":179764,"delay":0,"changeRate":0.026490066225165587,"nameEN":"ARTRYA LTD","floatShares":76766493,"shares":158084000,"eps":-0.172236,"marketStatus":"Closed","change":0.08,"latestTime":"03-05 16:12:00 AEDT","open":3.14,"high":3.16,"low":3.05,"amount":556712,"amplitude":0.036424,"askPrice":3.15,"askSize":1718,"bidPrice":3.05,"bidSize":327,"shortable":3,"etf":0,"ttmEps":-0.172236,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1772751600000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":3.02,"openAndCloseTimeList":[[1772665200000,1772686800000]],"volumeRatio":0.404892,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AYA.AU\",,,,,undefined,":{"symbol":"AYA.AU","floatShares":76766493,"roa":"-23.75%","roe":"-37.89%","lyrEps":-0.177705,"volumeRatio":0.404892,"shares":158084000,"dividePrice":0,"high":3.16,"amplitude":0.036424,"preClose":3.02,"low":3.05,"week52Low":0.56,"pbRate":"5.48","psRate":"16898.63","week52High":5.24,"institutionHeld":0,"latestPrice":3.1,"committee":-0.680196,"eps":-0.172236,"divideRate":0,"volume":179764,"delay":0,"ttmEps":-0.172236,"open":3.14,"prevYearClose":4.71,"prevWeekClose":3.4,"prevMonthClose":3.4,"prevQuarterClose":4.71,"fiveDayClose":3.22,"twentyDayClose":3.38,"sixtyDayClose":3.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AYA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AYA.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AYA.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614704894","title":"Artrya Ltd - Loss for Half-Year Attributable a$10.7 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2614704894","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614704894?lang=en_us&edition=fundamental","pubTime":"2026-02-25 16:59","pubTimestamp":1772009988,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nFWN3ZL0PU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2612422989","title":"Artrya Ltd-Appointment of Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2612422989","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612422989?lang=en_us&edition=fundamental","pubTime":"2026-02-19 06:10","pubTimestamp":1771452620,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nTUE3CSBRT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AYA.AU","BK7094"],"gpt_icon":0},{"id":"2608853813","title":"Change in substantial holding from WAX/WAA/WAM/WMI","url":"https://stock-news.laohu8.com/highlight/detail?id=2608853813","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608853813?lang=en_us&edition=fundamental","pubTime":"2026-02-02 14:52","pubTimestamp":1770015173,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260202:nASX2gKl2Z","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nASX2jscCy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AYA.AU","WAA.AU","WMI.AU","BK7094","WAM.AU","WAX.AU"],"gpt_icon":0},{"id":"2608827108","title":"Artrya Says US Health System Agrees to In-Principle Participation in Cardiovascular Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2608827108","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608827108?lang=en_us&edition=fundamental","pubTime":"2026-02-02 07:32","pubTimestamp":1769988773,"startTime":"0","endTime":"0","summary":"Artrya  said Dignity Health Arizona agreed to in-principle participation in the retrospective US multi-center SAPPHIRE Study, according to a Monday filing with the Australian bourse.The study will evaluate the clinical and prognostic value of the Salix plaque analysis and its plaque dispersion score to identify patients at elevated risk of cardiovascular events, the filing said.Additionally, the company plans to focus its upcoming study on women with coronary artery disease, which will include a group of women-only patients at risk, known as SAPPHIRE-WIN, per the filing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AYA.AU","BK7094","BK4082","CSII"],"gpt_icon":0},{"id":"2606273092","title":"BRIEF-Artrya Appoints Richard Jarvis As CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2606273092","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606273092?lang=en_us&edition=fundamental","pubTime":"2026-01-27 09:47","pubTimestamp":1769478459,"startTime":"0","endTime":"0","summary":"BRIEF-Artrya Appoints Richard Jarvis As CFOJan 27 (Reuters) - Artrya Ltd AYA.AX:RICHARD JARVIS APPOINTED AS CFOBEGINS EXECUTIVE SEARCH FOR PERMANENT CFOFurther company coverage: AYA.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nFWN3YR0QP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2606622175","title":"Artrya Ltd - Begins Executive Search for Permanent CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2606622175","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606622175?lang=en_us&edition=fundamental","pubTime":"2026-01-27 06:35","pubTimestamp":1769466938,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nFWN3YR0QP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2606221734","title":"Artrya Ltd - Richard Jarvis Appointed as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2606221734","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606221734?lang=en_us&edition=fundamental","pubTime":"2026-01-27 06:35","pubTimestamp":1769466938,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nFWN3YR0QP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2601837424","title":"ASX Growth Stocks With High Insider Ownership To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2601837424","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601837424?lang=en_us&edition=fundamental","pubTime":"2026-01-06 03:08","pubTimestamp":1767640120,"startTime":"0","endTime":"0","summary":"As the Australian market navigates a cautious start to 2026, with the ASX hovering just above the 8,700 level and mixed sector performances, investors are closely watching global events such as America's actions in Venezuela for potential impacts. In this environment of uncertainty and selective gains across sectors like materials, identifying growth companies with high insider ownership can be a strategic move, as these stocks often benefit from aligned interests between management and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-dvp/develop-global-shares/news/asx-growth-stocks-with-high-insider-ownership-to-watch-8","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-dvp/develop-global-shares/news/asx-growth-stocks-with-high-insider-ownership-to-watch-8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TTT.AU","AV1.AU","BK7094","BK7116","NWF.AU","EIQ.AU","DVP.AU","BK7104","BB1.AU","BK7016","SEA.AU","BK7095","BK7017","A4N.AU","3DP.AU","WZR.AU","BK7506","BK7117","BK7093","POL.AU","BK7036","AYA.AU","LM8.AU"],"gpt_icon":0},{"id":"2601420837","title":"Artrya And 2 Other High Growth Tech Stocks With Potential In Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2601420837","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601420837?lang=en_us&edition=fundamental","pubTime":"2026-01-06 03:06","pubTimestamp":1767639983,"startTime":"0","endTime":"0","summary":"As the Australian market kicks off 2026, the ASX has been relatively flat with a brief pause in the Santa Rally, while IT stocks have led declines amidst broader market uncertainties. In this environment, identifying high-growth tech stocks like Artrya and others requires careful consideration of their potential to navigate current challenges and capitalize on emerging opportunities within Australia's dynamic economic landscape.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-cgs/cogstate-shares/news/artrya-and-2-other-high-growth-tech-stocks-with-potential-in","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-cgs/cogstate-shares/news/artrya-and-2-other-high-growth-tech-stocks-with-potential-in","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XJO.AU","CGS.AU","BK7067","XKO.AU","BK7094","XAO.AU","AYA.AU","BK7508","CUV.AU"],"gpt_icon":0},{"id":"2594263302","title":"Artrya (ASX:AYA) Secures Cone Health In Five-Year SaaS Deal Is Its U.S. Beachhead Emerging?","url":"https://stock-news.laohu8.com/highlight/detail?id=2594263302","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594263302?lang=en_us&edition=fundamental","pubTime":"2025-12-26 04:25","pubTimestamp":1766694313,"startTime":"0","endTime":"0","summary":"Artrya Limited recently announced a five-year SaaS agreement with U.S. healthcare provider Cone Health to roll out its Salix Coronary Anatomy and Plaque AI imaging modules across the health system’s network, securing its third commercial customer in the United States.\nThis latest deal completes the conversion of all three of Artrya’s U.S. foundation partners, signalling growing clinical adoption and a deeper foothold in the competitive American cardiac imaging market.\nWe’ll now examine how...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-aya/artrya-shares/news/artrya-asxaya-secures-cone-health-in-five-year-saas-deal-is","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-aya/artrya-shares/news/artrya-asxaya-secures-cone-health-in-five-year-saas-deal-is","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AYA","AYA.AU","BK7094"],"gpt_icon":0},{"id":"2593456787","title":"Artrya Enters Agreement With US Foundation Partner for Clinical Use of Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2593456787","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593456787?lang=en_us&edition=fundamental","pubTime":"2025-12-23 07:37","pubTimestamp":1766446620,"startTime":"0","endTime":"0","summary":"Artrya  entered a five-year commercial agreement with Cone Health, for the use of the Salix cloud platform for the assessment and management of coronary artery disease, according to a Tuesday Australian bourse filing.The deal has a minimum value of $450,000, with additional per-scan revenue for the use of Salix's plaque module, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2590540876","title":"Artrya Reports First Fee per Scan Revenue From Salix Cloud Platform; Shares Hit All-Time High","url":"https://stock-news.laohu8.com/highlight/detail?id=2590540876","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590540876?lang=en_us&edition=fundamental","pubTime":"2025-12-12 08:03","pubTimestamp":1765497822,"startTime":"0","endTime":"0","summary":"Artrya  said its US customer, Tanner Health, has started the commercial use of the Salix cloud platform for the assessment and management of coronary artery disease, generating the first fee per scan revenues for the company, according to a Friday Australian bourse filing.Tanner Health used Salix's coronary plaque module at its Georgia hospital and will roll out the module to additional hospitals in the near term, the filing said. It can seek a $950 reimbursement for each assessment using the module, the filing added.Shares of the company rose past 4% in recent Friday trade and earlier hit an all-time high.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AYA.AU","BK7094"],"gpt_icon":0},{"id":"2589111386","title":"BUZZ-Australia's Artrya at three-week peak on deal with US co","url":"https://stock-news.laohu8.com/highlight/detail?id=2589111386","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589111386?lang=en_us&edition=fundamental","pubTime":"2025-12-08 12:44","pubTimestamp":1765169058,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Artrya at three-week peak on deal with US co** Artrya AYA.AX jumps as much as 12.8% to A$3.89, highest since November 12** Stock marks biggest intraday pct rise since November 20** Medical technology firm signs commercial agreement for use of its Salix platform with U.S.-based Northeast Georgia Health System** Agreement for three years with minimum value of $300,000 for SalixCoronary Anatomy platform, with additional fee-per-scan revenue from Salix Coronary Plaque module, Salix Coronary Flow module** AYA last up 9.6%; surges 613.2% YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nL6N3XE09K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2589043908","title":"Artrya Enters Agreement With US Foundation Partner for Clinical Use of Platform; Shares Rise 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589043908","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589043908?lang=en_us&edition=fundamental","pubTime":"2025-12-08 08:19","pubTimestamp":1765153156,"startTime":"0","endTime":"0","summary":"Artrya  entered a three-year commercial agreement with Northeast Georgia Health System  for the clinical use of Salix, the company's cloud platform for the assessment and management of coronary artery disease, according to a Monday filing with the Australian bourse.Under the deal, Salix will be used for patients with suspected or confirmed coronary artery disease undergoing CT angiography within the Georgia Heart Institute, the filing said.Salix will be licensed as a SaaS platform with a fixed monthly subscription fee, the filing added.Assessments performed using Salix's plaque module will generate fee-per-scan revenue, the company said.The company is preparing the US Food and Drug Administration submission for Salix's coronary flow module.Shares of the company rose 9% in recent Monday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2589801803","title":"ASX Growth Companies With High Insider Ownership December 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2589801803","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589801803?lang=en_us&edition=fundamental","pubTime":"2025-12-08 03:08","pubTimestamp":1765134481,"startTime":"0","endTime":"0","summary":"As the Australian market navigates a week of volatility with fluctuating investor sentiment, attention turns to growth companies that demonstrate resilience and potential through high insider ownership. In this context, stocks with significant insider stakes can be particularly appealing as they often indicate strong confidence from those who know the company best, aligning well with current market dynamics where stability and informed optimism are valued.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-dvp/develop-global-shares/news/asx-growth-companies-with-high-insider-ownership-december-20","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-dvp/develop-global-shares/news/asx-growth-companies-with-high-insider-ownership-december-20","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["3DP.AU","BK7084","IR1.AU","NWF.AU","A4N.AU","WZR.AU","BK7093","AYA.AU","BK7036","ELS.AU","BK7506","AV1.AU","POL.AU","LM8.AU","DVP.AU","BK7104","TTT.AU","BK7017","BK7016","BK7095","BK7094","EIQ.AU","BK7116"],"gpt_icon":0},{"id":"2589801801","title":"Exploring 3 High Growth Tech Stocks in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2589801801","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589801801?lang=en_us&edition=fundamental","pubTime":"2025-12-08 03:05","pubTimestamp":1765134332,"startTime":"0","endTime":"0","summary":"As the Australian market experiences a tentative rise, with shares initially pointing towards gains before potential afternoon reversals, investors are closely monitoring economic indicators and broader market sentiment that could impact small-cap stocks. In this environment, identifying high-growth tech stocks involves looking for companies that can navigate these fluctuations effectively while capitalizing on technological advancements and strategic opportunities in the sector.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-cgs/cogstate-shares/news/exploring-3-high-growth-tech-stocks-in-australia-10","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-cgs/cogstate-shares/news/exploring-3-high-growth-tech-stocks-in-australia-10","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7094","CUV.AU","BK7067","AYA.AU","XKO.AU","XAO.AU","XJO.AU","BK7508","CGS.AU"],"gpt_icon":0},{"id":"2583533847","title":"Artrya Says US Health System to Participate in Study on Early Coronary Artery Disease Detection; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583533847","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583533847?lang=en_us&edition=fundamental","pubTime":"2025-11-13 09:40","pubTimestamp":1762998032,"startTime":"0","endTime":"0","summary":"Artrya  said US non-profit health system Ascension agreed to participate in its multi-center clinical SAPPHIRE study, according to a Thursday filing with the Australian bourse.The study, which will start in 2026, is designed to assess how the company's Salix cloud platform and plaque dispersion score can provide early detection of coronary artery disease, and includes a focus on improving care for women, the filing said.Shares rose 3% in midday trade on Thursday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK6045","BK6520","BK7094","BRD.SI","AYA.AU"],"gpt_icon":0},{"id":"2582903468","title":"Assessing Artrya (ASX:AYA) Valuation Ahead of Q1 2026 Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2582903468","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582903468?lang=en_us&edition=fundamental","pubTime":"2025-11-09 18:23","pubTimestamp":1762683799,"startTime":"0","endTime":"0","summary":"Artrya (ASX:AYA) is on investors’ radar this week, as anticipation grows ahead of its Q1 2026 earnings call scheduled for October 29, 2025. Market watchers are waiting to see how recent trends translate into results.\nSee our latest analysis for Artrya.\nMomentum has been building for Artrya, with a 27.6% share price return over the past month and a remarkable 445.2% year-to-date. Over the last twelve months, total shareholder return stands at an impressive 576.0%, highlighting the surge in...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-aya/artrya-shares/news/assessing-artrya-asxaya-valuation-ahead-of-q1-2026-earnings","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-aya/artrya-shares/news/assessing-artrya-asxaya-valuation-ahead-of-q1-2026-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AYA.AU","AYA"],"gpt_icon":0},{"id":"2581856842","title":"Can Anticipation Around Artrya (ASX:AYA)'s Earnings Call Reveal Shifts in Investor Confidence?","url":"https://stock-news.laohu8.com/highlight/detail?id=2581856842","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581856842?lang=en_us&edition=fundamental","pubTime":"2025-11-08 08:39","pubTimestamp":1762562366,"startTime":"0","endTime":"0","summary":"Artrya Limited has announced its upcoming Q1 2026 earnings call, scheduled for October 29, 2025, signaling a key moment for stakeholders awaiting developments from the company.\nThis earnings call has captured increased user attention, reflecting heightened anticipation in the absence of other major company announcements in recent weeks.\nWe'll explore how anticipation around Artrya's upcoming earnings call shapes the company's investment narrative and investor expectations.\nExplore 27 top...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-aya/artrya-shares/news/can-anticipation-around-artrya-asxayas-earnings-call-reveal","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-aya/artrya-shares/news/can-anticipation-around-artrya-asxayas-earnings-call-reveal","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AYA","AYA.AU"],"gpt_icon":0},{"id":"2581011155","title":"Buy Hold Sell: The hottest ASX small caps right now (and 2 on the rise)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581011155","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581011155?lang=en_us&edition=fundamental","pubTime":"2025-11-07 04:00","pubTimestamp":1762459215,"startTime":"0","endTime":"0","summary":"Unless you've been living under a rock, chances are you're aware of the resurgence in small-cap stocks. The ASX Small Ordinaries is up 19% year-to-date, versus just 7% for the ASX 100.But it's not just a rotation away from growth-starved large caps that is seeing smalls catch a bid. The recent reporting season showed that many small caps are in rude health, with strong balance sheets and improved earnings backed by margin expansion, built on a bedrock of innovation and competitive advantage.That's the good news but, of course, not all small caps are created equal. Investors need to be highly selective when considering less mature businesses.Against that backdrop, Livewire's Chris Conway sat down withJames Nguyen from Tyndall and Shaun Weick from Wilson Asset Management to understand their most important factors when assessing companies and run the ruler over three of the hottest ASX small caps.For good measure, they each share a small-cap name they believe is on the rise.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/buy-hold-sell-the-hottest-asx-small-caps-right-now-and-2-on-the-rise","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/buy-hold-sell-the-hottest-asx-small-caps-right-now-and-2-on-the-rise","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["GDG.AU","BK7094","BUY","HOLD","SDV.AU","BK7062","COG.AU","BK7089","MQG.AU","BK7046","AYA.AU","BK7142","BK7054","BK7511","BUY.AU","NWL.AU","BK7017"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}]}}